Who Sets the Agenda for Global Health?



In the past two decades, cross-border and international health challenges together with their risks factors, have mobilized unmatched attention and resources. Once led by a few United Nations organizations,  global health has attracted hundreds of new actors, ranging from public to private sector organizations including foundations. With the plurality, comes the challenge to coordinate international health work and avoid needless duplication and wastes. And the absence of clear practice to set agenda, unveils a growing gulf between health needs and where resources are spent.

What interests, values and mechanisms underpin global health governance?  In a recent article, Dr. Devi Sridhar argues that, the complex manner of setting agenda, ‘’is a consequence of a general phenomenon in global health, where the nature and type of funding dictates priorities[1]..’’ She calls the emerging trend ‘’multibi-funding:’’ donors increasingly earmarked and channeled their support through traditional multilateral organisations and new multi-stakeholder initiatives to specify diseases, countries and regions of their interests.

The opaque manner in setting priorities runs counter to evidence-based approach, a cornerstone in public health. Through the practise, donors, including private foundations, cherry pick diseases that get attention and support.  As a consequence, much needed resources are diverted away from where needs are greatest. For example, the Bill Gates funded Institute for Health Metrics and Evaluation estimates that in 2010, non-communicable diseases— like cancer, diabetes and hypertension— the biggest killers, received less than 3 percent of the 28 billion dollars international assistance to health.  In contrast, HIV/AIDS, malaria and tuberculosis together attracted 31 percent of the overall global health resources.  Donors tie their support to specific programs within United Nations organizations like WHO, as well as channel a lion’s share of their contributions to vertical funds like the Global Fund to fight HIV/AIDS, Tuberculosis, and Malaria and the Global Action for Vaccines and Immunization (GAVI).

Praise for the progress to achieve health MDGs, disease-specific initiatives however, have added complexity, uncertainty and even chaos to the business of global health. Their innovative decision-making structures raise some important concerns about accountability and legitimacy. Whereas Member States are the only vote holders in key United Nations organizations, decision-making in global health initiatives is by a selected number of donors and non-governmental organizations. Even though, total funds for health have quadrupled over the years, allocation to priorities is unpredictable. Global health initiatives with their specific mandates are funded entirely by voluntary contributions. Intergovernmental health organizations, with their broad mandates have witnessed an exponentially growth in their unpredictable non-core budgets, as long-term, core funds remain flat.

The shift in funding channels has significant implications for global health governance. What donors are unable to achieve in open-multilateral forums, where each country has a vote, they turn to closed ‘’market places’’, where money counts. As a consequence, short term gains are favored over coordinated efforts to address long-term health challenges. An even greater risks, is undermining core capacities of traditional global health institutions, which rely on fixed, predictable, long-term funds to collate and disseminate vital information about diseases, a foundation of global health research.

It remains unclear whether business will continue as usual, at least in the short-term. Health appears to have buck a downward trend of cuts to international development work. Funding  has recovered to pre-crisis levels, perhaps dissipating the urgency to reform, introduced by the global financial. Emerging economies are reluctant to use the power of their purse to shake up the status quo, too. 




[1] Sridhar D (2012) Who Sets the Global Health Research Agenda? The Challenge of Multi-Bi
Financing. PLoS Med 9(9): e1001312. doi:10.1371/journal.pmed.1001312

Comments

Popular posts from this blog

The Africa Mining Vision after the Boom

Strategic narratives autonomy matter more than industrial policy

Wanted: Farsighted African Leadership against Ebola